Showing results (101-110 of 111) with videos related to
Sort By:
Pageof 12
Anticancer Research|August 5, 2010
Phase III study comparing sequential versus alternate administration of cisplatin-etoposide and topotecan as first-line treatment in small cell lung cancerSophia Baka, Sophia Agelaki, Athanasios Kotsakis, et al.Cancer|May 11, 2013
Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 studyAthanasios Karampeazis, Alexandra Voutsina, John Souglakos, et al.Cancer Chemotherapy and Pharmacology|July 13, 2011
Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)Ioannis Boukovinas, Nikolaos Androulakis, Nikolaos Kentepozidis, et al.Breast Cancer Research and Treatment|November 20, 2008
Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevanceStella Apostolaki, Maria Perraki, Galatea Kallergi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2006
Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patientsNikos Xenidis, Maria Perraki, Maria Kafousi, et al.Breast Cancer Research and Treatment|July 29, 2009
FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)Aristides Polyzos, Nikolaos Malamos, Ioannis Boukovinas, et al.International Journal of Cancer|February 6, 2020
BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effectsParaskevi Apostolou, Florentia Fostira, Charalambos Kouroussis, et al.Clinical Chemistry|July 29, 2021
A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast CancerAreti Strati, Martha Zavridou, Galatea Kallergi, et al.Breast Cancer Research : BCR|April 25, 2014
International study on inter-reader variability for circulating tumor cells in breast cancerMichail Ignatiadis, Sabine Riethdorf, François-Clement Bidard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled AnalysisWolfgang Janni, Thomas W P Friedl, Tracy C Yab, et al.Pageof 12